New method of embolus preparation for standardized embolic stroke in rabbits

Stroke

Volumn 33, Issue 9, 2002, Pages 2329-2333

  Kirchhof, Klaus ^a   Welzel, Thomas ^a   Zoubaa, Saida ^a   Lichy, Christoph ^a   Sikinger, Marcus ^b   De Ruiz, Hildegard Lorbacher ^a   Sartor, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Animal models; Rabbits; Thromboembolism

Indexed keywords

FIBRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD CELL; BLOOD CLOT LYSIS; BRAIN BLOOD VOLUME; BRAIN EMBOLISM; BRAIN PERFUSION; CONTROLLED STUDY; ERYTHROCYTE; FIBRIN CLOT; HISTOPATHOLOGY; INCIDENCE; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; STANDARDIZATION; STROKE; TECHNIQUE;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; BRAIN; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FIBRIN; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL EMBOLISM; MALE; RABBITS; REPRODUCIBILITY OF RESULTS;

EID: 0036712355     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000027436.82700.73     Document Type: Article

References (26)

1. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke
2. Effect of intra-arterial antifibrinolytic agents on autologous arterial emboli in the cerebral circulation of rabbits
3. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits
4. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS)
6. The ECASS 3-hour cohort
7. Tissue plasminogen activator for acute ischemic stroke
8. Clinical trials in acute stroke: Why have they not been successful?
9. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model
10. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke
11. Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model
12. Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke
13. Internal carotid artery occlusion: A study of 61 instances in 50 patients with post-mortem data
14. Ischaemic cerebrovascular diseases in an autopsy series, part 2: Prevalence, location, pathogenesis, and clinical course of cerebral infarcts
15. Thrombotic and embolic occlusions of the carotid arteries in an autopsy series, part 2: Cerebral lesions and clinical course
16. The pathogenesis of coronary thrombus
17. Experimental platelet and coagulation thrombi
18. Lysing patterns of retracted blood clots with diffusion or bulk flow transport of plasma with urokinase into clots: A magnetic resonance imaging study in vitro
19. Flow through clots determines the rate and pattern of fibrinolysis
20. Fibrin has larger pores when formed in the presence of erythrocytes
21. Gerinnunsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
22. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat
23. Role of thrombosis and atherosclerosis and its complications
24. Morphogenesis of occluding coronary artery thrombosis
25. Platelet disintegration during clotting
26. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: Quantitative angiographic observations